Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CEP57 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of CEP57 mRNA | increases expression | 20406850
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of CEP57 mRNA | increases expression | 14703492
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CEP57 mRNA | decreases expression | 20018196 19150397
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of CEP57 mRNA | decreases expression | 20678512
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of CEP57 mRNA | decreases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CEP57 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine results in decreased expression of CEP57 mRNA | decreases expression | 19363521
|
C014347 |
decitabine |
TP53 protein affects the reaction [decitabine results in decreased expression of CEP57 mRNA] | affects reaction|decreases expression | 19363521
|
D008727 |
Methotrexate |
CEP57 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D016685 |
Mitomycin |
CEP57 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
D011374 |
Progesterone |
Progesterone results in increased expression of CEP57 mRNA | increases expression | 18070364
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA | affects cotreatment|decreases expression | 19244175
|
D012643 |
Selenium |
Selenium results in decreased expression of CEP57 mRNA | decreases expression | 19244175
|
C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of CEP57 mRNA | affects expression | 17440010
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA | affects cotreatment|decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of CEP57 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
4.33 | 12039119 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
2.30 | 19825857 11798837 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.11 | 17286800 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.72 | 16206674 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.92 | 11985600 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.43 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
4.33 | 15665606 15380490 15845082 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.05 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.05 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.05 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
2.05 | 17614352 15562024 16175315 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.39 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.00 | 16050911 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.63 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.63 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
4.63 | 14691202 15073043 16217749 11135700 15553829 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.07 | 17123778 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.97 | 19014326 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.17 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.61 | 19215824 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.35 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.35 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.35 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.95 | 19486331 |
MESH:D003092 |
Colitis |
|
Selenium |
3.85 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.59 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.59 | 18981723 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.25 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.99 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
3.99 | 12039119 9562676 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
3.99 | 19769572 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.14 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
11.14 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.29 | 19747007 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.15 | 15213294 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.19 | 20191521 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.56 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.34 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.34 | 15131321 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.80 | 9068938 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
3.84 | 17692515 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.21 | 19294695 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
3.82 | 16134523 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.50 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.50 | 12903497 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
7.93 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.93 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.21 | 12168785 12639820 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.33 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.30 | 8708960 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.22 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.52 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.01 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.11 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.50 | 15720958 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.72 | 16490937 16863852 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.84 | 17440010 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.07 | 14716179 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.12 | 10903974 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.47 | 15869954 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
3.24 | 17581917 |
MESH:D007249 |
Inflammation |
|
Progesterone |
2.62 | 15869954 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
11.29 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
11.29 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.32 | 16393666 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.54 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.12 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
6.12 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.94 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
12.63 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
12.63 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.63 | 12371664 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.16 | 9562676 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
6.54 | 15070760 |
MESH:D007938 |
Leukemia |
|
decitabine |
6.54 | 18980019 19235587 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.85 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.39 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.47 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
9.77 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
9.77 | 18454857 19117987 17236224 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.02 | 20471514 19850784 17050201 16467208 16968895 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
4.02 | 19010910 17679729 18206229 18460780 19387464 18704418 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.56 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.25 | 15622746 15748426 19075265 15336539 17217047 11161223 9834237 16966277 19035177 12679006 19642359 16330433 16891316 19225113 16823087 17869043 17712046 16331271 15213294 11468182 17649720 16112521 17107899 12018890 12712474 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.42 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.73 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
1.90 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
7.72 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
7.72 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
7.72 | 15113037 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
6.07 | 2876786 6135515 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
6.07 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.39 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.21 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.12 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
2.55 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
2.55 | 11062179 |
MESH:D008223 |
Lymphoma |
|
decitabine |
8.03 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
8.03 | 17352296 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.24 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.24 | 15318939 |
MESH:D008545 |
Melanoma |
|
decitabine |
2.25 | 17785578 16505122 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.81 | 15107826 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.88 | 16801185 |
MESH:C536987 |
Mosaic variegated aneuploidy syndrome |
marker/mechanism |
|
| 21552266 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.36 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
7.50 | 14977855 19417148 15949261 19549372 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.50 | 18172295 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.77 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.60 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
7.60 | 19157545 16882708 19010910 18608210 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.63 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.63 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.02 | 16624393 |
MESH:D009369 |
Neoplasms |
|
decitabine |
2.73 | 19116145 17925555 19470736 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.54 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.33 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.04 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
3.15 | 10525206 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.06 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.06 | 16049721 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.07 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
8.05 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
8.05 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
8.05 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
8.90 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.90 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
8.90 | 15113037 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.22 | 19927285 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.99 | 15087411 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.27 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.03 | 10548101 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.80 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.26 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.60 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.60 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.60 | 15084515 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
5.97 | 16882103 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
5.97 | 17410198 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.87 | 10548101 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.78 | 17352296 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.46 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.87 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.02 | 16646077 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.99 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.99 | 18551238 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.45 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.71 | 8532709 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
4.36 | 16503802 15862959 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.58 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.58 | 19037991 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.56 | 16517955 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.07 | 16684133 16045194 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.10 | 9562676 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.46 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.46 | 17967635 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.04 | 15213294 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
12.11 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
12.11 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
12.11 | 12845720 20435036 11780464 12973940 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
12.11 | 17616700 19087683 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.27 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.27 | 10091137 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.11 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.01 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.08 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.54 | 17120751 |